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Abstract. The intensification of control interventions has led to marked reductions in malaria burden in some settings,
but not others. To provide a comprehensive description of malaria epidemiology in Uganda, we conducted surveillance
studies over 24 months in 100 houses randomly selected from each of three subcounties: Walukuba (peri-urban), Kihihi
(rural), and Nagongera (rural). Annual entomological inoculation rate (aEIR) was estimated from monthly Centers for
Disease Control and Prevention (CDC) light trap mosquito collections. Children aged 0.5–10 years were provided long-
lasting insecticidal nets (LLINs) and followed for measures of parasite prevalence, anemia and malaria incidence.
Estimates of aEIR were 2.8, 32.0, and 310 infectious bites per year, and estimates of parasite prevalence 7.4%, 9.3%,
and 28.7% for Walukuba, Kihihi, and Nagongera, respectively. Over the 2-year study, malaria incidence per person-years
decreased in Walukuba (0.51 versus 0.31, P = 0.001) and increased in Kihihi (0.97 versus 1.93, P < 0.001) and Nagongera
(2.33 versus 3.30, P < 0.001). Of 2,582 episodes of malaria, only 8 (0.3%) met criteria for severe disease. The prevalence
of anemia was low and not associated with transmission intensity. In our cohorts, where LLINs and prompt effective
treatment were provided, the risk of complicated malaria and anemia was extremely low. However, malaria incidence
was high and increased over time at the two rural sites, suggesting improved community-wide coverage of LLIN and
additional malaria control interventions are needed in Uganda.
INTRODUCTION
The intensification of malaria control interventions, including
long-lasting insecticidal nets (LLINs), indoor residual spraying
(IRS) of insecticides, and prompt treatment with artemisinin-
based combination therapies (ACTs) has been accompanied
by marked reductions in transmission intensity, parasite prev-
alence, malaria incidence, malaria-associated hospitalizations,
and malaria-associated deaths in some settings,1–6 but not
others.7,8 To date, substantial successes in malaria control in
sub-Saharan Africa have been mostly limited to relatively
low-transmission settings. Comparatively, there have been
fewer studies documenting the transitioning epidemiology in
areas of high malaria transmission, such as Uganda, where the
greatest burden of malaria in Africa remains focused.9,10 A
better understanding of the complex relationships between
malaria transmission, infection, and disease is important to
support the targeted use of control interventions, and maximize
their impact.
Exposure of individuals to malaria parasites is typically
estimated by the entomological inoculation rate (EIR), which
is an estimate of the number of infective bites received per
person per unit time, usually a transmission season or 1 year.
In Uganda, the limited available data document significant
heterogeneity of malaria transmission, ranging from under 10
to several hundred infective bites per person year.11 Whether
inoculation with sporozoites leads to patent infection and clin-
ical disease depends on the ability of the host to control or
clear parasites. Fortunately, in endemic areas most infections
do not lead to symptomatic disease because of the develop-
ment of clinical immunity. Immunity develops as a result of
repeated exposure, first leading to protection against severe
forms of disease, followed by protection against symptomatic
illness.12 Protection against illness is accompanied by a rise in
the prevalence of asymptomatic parasitemia, in large part
since asymptomatic individuals are less likely to receive anti-
malarial treatment.13–15 In addition, there is an increasing
appreciation of the role of sub-patent infections among asymp-
tomatic individuals, which may also proportionally increase
with increasing immunity.16 Asymptomatic parasitemia pro-
vides a reservoir for transmission and may be associated with
adverse health outcomes such as anemia.17 An important met-
ric for estimating malaria morbidity is malaria incidence,
defined as the number of cases per person per time at risk.
Incidence is best estimated using longitudinal studies of rep-
resentative cohorts, in which all cases of suspected malaria are
captured and accurately diagnosed.
To provide a comprehensive and contemporary description
of malaria epidemiology in Uganda, we conducted entomologic
surveys and prospective cohort studies in children from the
same households, randomly selected from three sites with
varied transmission intensity. Key metrics included measures
of malaria transmission (EIR), infection (parasite preva-
lence), and disease (malaria incidence, severity of illness, and
prevalence of anemia).
MATERIALS ANDMETHODS
Description of malaria in Uganda and study sites. The most
recent national data on malaria epidemiology in Uganda come
from a Malaria Indicator Survey (MIS) conducted in 2009.18
Malaria was endemic in over 95% Uganda, with a parasite
prevalence of 42% among children under 5 years of age. Over
98% of infections are caused by Plasmodium falciparum.
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Detailed entomological surveys were last conducted in 2002;
then the major mosquito vectors reported were Anopheles
gambiae s.s. and to a lesser extent An. funestus.11 Recent
reports by our group show a decline of An. funestus and
emergence of An. arabiensis.19 Malaria transmission is peren-
nial, with two annual peaks following the two rainy seasons
(March–May and August–October).
For this report, comprehensive surveillance studies were
conducted in three subcounties: Walukuba, Jinja District;
Kihihi, Kanungu District, and Nagongera, Tororo District
(Figure 1). These areas were purposively chosen to represent
varied malaria transmission settings. Walukuba is a relatively
low-transmission, peri-urban area near Lake Victoria in the
south central part of the country. Kihihi is a rural area with
moderate transmission intensity, which borders a national
park in the southwestern part of the country. Nagongera is a
rural area with high transmission intensity in the southeastern
part of the country near the border with Kenya. Notable
regional malaria control interventions included a single round
of IRS using lambda-cyhalothrin in Kanungu District in
200720 and a mass, community-based distribution of free
LLINs in Tororo District in January 2011. Additional descrip-
tive characteristics of the study sites are available from an
enumeration survey described below and a cross-sectional
community survey conducted in 2012, which randomly
selected households from each subcounty (Sarah G. Staedke,
unpublished data).
Enumeration survey and selection of households for partic-
ipation in surveillance studies. All households within each of
the three subcounties were enumerated and mapped using
handheld global positioning systems (Garmin e-Trex 10 GPS
unit, Garmin International Inc., Olathe, KS). A household was
defined as any single permanent or semipermanent dwelling
acting as the primary residence for a person or group of people
that generally cook and eat together. Using a computerized
number generator, random samples of households from each
subcounty were approached consecutively, and 100 households
were enrolled per site into both the entomologic surveys and
cohort studies if they met the following criteria: 1) at least one
household resident 0.5–10 years of age and 2) at least one adult
resident available for providing informed consent.
Entomologic surveys. Entomological surveys were con-
ducted once a month from August 2011 to September 2013 in
each household using miniature Centers for Disease Control
and Prevention (CDC) light traps (Model 512; John W. Hock
Company, Gainesville, FL) with the light positioned 1 m
above the floor at the foot end of the bed where a cohort
study participant slept. Traps were set at 7.00 PM and collected
at 07.00 AM the following morning by field workers. Methods
used for the processing of mosquito specimens and identifica-
tion of sporozoites were as described previously (processing
of mosquito specimens in methods section).19
Enrollment and follow-up of cohort study participants. All
children from each household were enrolled into the cohort
Figure 1. Map of Uganda showing study sites.
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study if they met the following eligibility criteria: 1) docu-
mented age between 6 months and less than 10 years, 2) full-
time resident of the household, 3) no intention to move out of
the subcounty for the next 2 years, 4) agreement to come to a
dedicated study clinic located within the subcounty for any
febrile illness, 5) agreement to avoid antimalarial medications
administered outside the study, and 6) provision of written
informed consent from parent or guardian. The cohorts were
followed from August 2011 to September 2013, and they were
dynamic, such that all newly eligible children from participat-
ing households were enrolled and study participants who
reached 11 years of age were excluded from further follow-up.
At enrollment, study participants and their parents/guardians
were given a LLIN and underwent a standardized evaluation
including a history, physical examination, and collection
of blood for hemoglobin (Hb) measurement and thick/thin
blood smear.
Cohort study participants received all medical care free of
charge at a designated study clinic open every day. Parents/
guardians were encouraged to bring their children to the clinic
any time they were ill and were reimbursed for transport
costs. Participants who required inpatient care were referred
to the local district hospital. Children who presented with a
documented fever (tympanic temperature ³ 38.0°C) or his-
tory of fever in the previous 24 hours had blood obtained by
finger prick for a thick blood smear. If the smear was positive,
the patient was diagnosed with malaria, and an Hb measure-
ment and thin blood smear for parasite species identification
were performed. Episodes of uncomplicated malaria were
treated with artemether-lumefantrine (AL), the recommended
first-line treatment in Uganda, administered at home twice a
day for 3 days. Episodes of complicated malaria (severe
malaria or danger signs)21 or recurrent malaria occurring
within 14 days of prior therapy were treated with quinine.
For patients with anemia (Hb < 10 gm/dL), Integrated Man-
agement of Childhood Illness guidelines were followed, with
administration of iron sulfate (100 mg daily for 2 weeks)
and mebendazole (only children > 1 year of age; 250 mg age
1–2 years; 500 mg > 2 years age; no more than every 6 months).
Routine evaluations, including thick blood smears, Hb mea-
surements, and assessment of adherence with LLINs by self-
report (did the child sleep under an LLIN the prior evening),
were done every 3 months. Study participants were withdrawn
from the study for 1) permanent movement out of the sub-
county, 2) inability to be located for > 4 months, 3) withdrawal
of informed consent, 4) inability to comply with the study
schedule and procedures, or 5) reaching 11 years of age.
Laboratory procedures. Thick and thin blood smears were
stained with 2% Giemsa for 30 minutes and read by labora-
tory technologists at the field sites who were not involved in
direct patient care. Parasite densities was calculated by
counting the number of asexual parasites per 200 leukocytes
(or per 500 leukocytes, if the count was < 10 asexual parasites/
200 leukocytes), assuming a leukocyte count of 8,000/mL. A
blood smear was considered negative when the examination
of 100 high-power fields did not reveal asexual parasites. Thin
smears were used for parasite species identification. For qual-
ity control, all slides were read by a second microscopist, and
discrepancies resolved by a third reviewer at the field sites.
In addition, all positive blood smears with a parasite densities
£ 20,000/mL based on the field readings were reread by an
expert microscopist based in Kampala, Uganda, and had to
be confirmed to be considered positive in the final analyses.
Hb measurements were performed using a portable spectro-
photometer (HemoCue, A¨ngelholm, Sweden).
Statistical analysis. All data were collected using standard-
ized case record forms and double entered using Microsoft
Access (Microsoft Corporation, Redmond, WA). Analyses
were performed using Stata, version 12 (Stata Corporation,
College Station, TX), and R version 2.15 (R Core Team
(2013), Vienna, Austria). Estimates of monthly rainfall were
obtained from the NASA Tropical Rainfall Measuring Mis-
sion Project.22 Data for this report covers the period from
October 2011 (the first full month following enrollment of
study households) through September 2013. Descriptive sta-
tistics included proportions and incidence measures using
standard techniques for estimating 95% confidence intervals.
The annual human biting rate was calculated as the total
number of female Anopheles mosquitoes captured/number of
house nights of collection + 365 days/year. The sporozoite
rate was calculated as the number of mosquitoes testing posi-
tive for sporozoites/the number of mosquitoes tested. The
annual EIR (aEIR) was the product of the annual human
biting rate and the sporozoite rate. Routine blood smears
were done every 3 months. Parasite prevalence was calculated
as the number of routine blood smears positive for asexual
parasites/total number of routine blood smears done. The
incidence of malaria was calculated as the number of episodes
of malaria/person-years of observation. Comparisons of changes
in incidence measures over time were made using negative
binomial regression models. Comparisons of change in preva-
lence measures over time were made using generalized estimat-
ing equations with adjustment for repeated measures in the
same study participant. A P value < 0.05 was considered statis-
tically significant.
Ethics statement. Ethical approval was obtained from the
Makerere University School of Medicine Research and Ethics
Committee, the Uganda National Council for Science and
Technology, the London School of Hygiene and Tropical
Medicine Ethics Committee, the School of Biological and
Biomedical Sciences Ethics Committee, Durham University
and the University of California, San Francisco Committee
on Human Research.
RESULTS
Characteristics of the study sites. Characteristics of the
three subcounties are presented in Table 1. Population-level
coverage estimates of key malaria control interventions were
from separate cross-sectional studies done from January–June
2012 in 200 households from each subcounty (Sarah G. Staedke,
unpublished data). The proportion of households reporting
ownership of at least one LLIN ranged from 51.0% in Kihihi
to 78.5% in Nagongera. The proportion of households with at
least one LLIN per two residents was significantly lower,
ranging from 17.0% in Kihihi to 35.5% in Nagongera. The
higher level of LLIN coverage in Nagongera is likely explained
by a mass distribution campaign conducted in Tororo District
in 2011. In the cohort studies described below, all children and
their primary care givers were given a LLIN at enrollment,
and over 99% of study participants reported sleeping under a
LLIN the prior night at the time of routine assessments done
every 3 months. None of the study sites were part of a govern-
ment IRS program, and only 2.5% of the houses in Walukuba
EPIDEMIOLOGY OF MALARIA IN UGANDA 905
reported IRS in the previous 12 months. Reported ACT cov-
erage among children with recent fever treated with an anti-
malarial ranged from 75.0% to 82.1% at the three sites using
population-level estimates.With initiation of the cohort studies,
all children presenting to our study clinics with a recent fever
and laboratory confirmed malaria were treated with AL, and
over 94% were treated within 3 days of onset of fever.
Study profile.Details of screening, enrollment, and follow-up
of households and study participants are presented in Figure 2.
To enroll 300 households (100 per subcounty), 466 were
screened. Of the 166 households excluded, 159 (96%) were
due to having no children within the target age range or the
house being unoccupied. Of 765 children initially screened,
755 (99%) were enrolled, ranging from 213 in Walukuba to
298 in Kihihi. An additional 123 children were enrolled during
dynamic recruitment and 175 were excluded over the 2-year
observation period, primarily due to reaching 11 years of age
or moving out of the study subcounties. During follow-up, the
number of routine visits done every 3 months ranged from
1,826 in Walukuba to 2,611 in Kihihi. The mean age of study
participants was similar across the three sites, ranging from 5.2
to 5.6 years (Table 2). Of a total of 13,811 visits to the study
clinics after enrollment, in only 12 (0.1%) instances was outside
medical care reported, including seven times when antimalarial
Table 1
Study site characteristics
Characteristic
Study site
Walukuba Kihihi Nagongera
Altitude above sea level, range 1,102–1,500 m 886–1,329 m 695–1,443 m
Setting Peri-urban Rural Rural
Population estimate (UBOS) 31,900 55,700 37,500
Total number of households 9,881 12,774 6,992
Median number of household residents (range) 3 (1–13) 4 (1–11) 5 (1–15)
Households with at least one LLIN 57.5% 51.0% 78.5%
Households with at least one LLIN per 2 residents 28.5% 17.0% 35.5%
Households receiving IRS in prior 12 months 2.5% 0 0
ACT use in children with fever treated with an antimalarial 75.0% 82.1% 77.8%
ACT = artemisinin-based combination therapies; LLIN = long-lasting insecticidal nets; IRS = indoor residual spraying, UBOS = Uganda Bureau of Statistics.
Figure 2. Enrolment and follow-up of study participant at the three study sites.
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drugs were prescribed (all without laboratory confirmation
and not included as episodes of malaria in our analyses).
Measures of transmission.Monthly mosquito collections from
each household resulted in 2,358, 10,370, and 100,890 female
anopheles and annual human biting rates of 394, 1,681, and
15,811 from Walukuba, Kihihi, and Nagongera, respectively
(P < 0.001 for all pairwise comparisons). The sporozoite rate
was similar in Kihihi (1.91%) and Nagongera (1.96%), but
significantly lower in Walukuba (0.71%; P < 0.001 for both
pairwise comparisons). The aEIR was estimated to be 2.8 in
Walukuba, 32.0 in Kihihi, and 310 in Nagongera (P < 0.001 for
all pairwise comparisons) (Table 2).
Measures of infection. The overall parasite prevalence was
similar in Walukuba and Kihihi (7.4% versus 9.3%, P = 0.23),
but significantly higher in Nagongera (28.7%) compared with
the other 2 sites (P < 0.001 for both pairwise comparisons)
(Table 2). The parasite prevalence peaked at approximately
8% around 3 years of age in Walukuba and at approximately
11% around 7 years of age in Kihihi, and then remained
relatively constant. In Nagongera, the parasite prevalence
increased with increasing age, reaching approximately 34%
at 10 years of age (Figure 3).
Measures of disease. The incidence of malaria was 0.43 epi-
sodes per person-years (PPY) in Walukuba, 1.43 episodes PPY
in Kihihi, and 2.81 episodes PPY in Nagongera (P < 0.001 for
all pairwise comparisons) (Table 2). In two of the three sites
(Kihihi and Nagongera), the incidence of malaria increased
from age 6 months to approximately 3 years of age. However,
the age and rate at which the incidence of malaria declined
(a sign of the development of clinical immunity) varied across
the sites. In Walukuba, the incidence of malaria was ~0.4 epi-
sodes PPY, with little variation from 2 to 8 years of age,
followed by a gradual decline (Figure 4). In Kihihi, the inci-
dence peaked at ~1.8 episodes PPY, with little variation from
3 to 6 years of age, followed by a gradual decline to ~1.0 epi-
sodes PPY. In Nagongera, the incidence peaked at ~4.3 epi-
sodes PPY, with a sharp decline from 3 to 10 years of age to
~1.3 episodes PPY. Of the 2,582 treatments given for malaria,
2,555 (99.0%) were for uncomplicated disease, 19 (0.7%) were
for danger signs, and only 8 (0.3%) were for episodes that met
criteria for severe malaria (5 with multiple convulsions, 2 with
severe anemia (Hb < 5 g/dL), and 1 with respiratory distress).
There were no deaths due to malaria, although two children
died of diarrheal illnesses with negative blood smears. 99.7%
of malaria episodes were due to P. falciparum. Response to
treatment with AL was excellent, with only three episodes
Table 2
Comparison of measures of transmission, infection, and disease across the three study sites
Study site
Walukuba Kihihi Nagongera
Characteristics of study subjects
Number of households enrolled 100 100 100
Number of children enrolled 251 327 300
Person years of observation 423 597 550
Number of routine visits 1,826 2,611 2,380
Number of febrile visits* 1,140 1,903 3,425
Mean age in years during follow-up 5.2 5.6 5.6
Measures of transmission
Annual human biting rate (95% CI) 394 (378–410) 1,681 (1649–1713) 15,811 (15714–15909)
Sporozoite rate (95% CI) 0.71% (0.41–1.15%) 1.91% (1.59–2.27%) 1.96% (1.84–2.09%)
aEIR (95% CI) 2.8 (1.6–4.5) 32.0 (26.7–38.1) 310 (291–330)
Measures of infection
Parasite prevalence (95% CI)† 7.4% (6.2–8.7%) 9.3% (8.2–10.5%) 28.7% (26.8–30.5%)
Measures of disease
Episodes of malaria 182 854 1,546
Uncomplicated malaria 180 841 1,534
Danger signs 1 9 9
Severe malaria 1 4 3
Slide positivity rate (95% CI)‡ 16.0% (13.9–18.2%) 44.9% (42.6–47.1%) 45.1% (43.5–46.8%)
Incidence of malaria PPY (95% CI) 0.43 (0.37–0.50) 1.43 (1.34–1.53) 2.81 (2.67–2.95)
Prevalence of anemia§ (95% CI)† 25.3% (23.3–27.4%) 15.4% (14.1–16.9%) 29.0% (27.1–30.8%)
aEIR = annual entomological inoculation rate; CI = confidence interval; PPY = per person-year.
*Tympanic temperature ³ 38.0 °C or history of fever in the previous 24 hours.
†Measured at the time of three monthly routine visits.
‡Proportion of febrile visits where malaria diagnosed.
§Hemoglobin < 11 g/dL.
Figure 3. Parasite prevalence by age at the three study sites with
varying malaria transmission intensity. Curves for each site were
fitted using locally weighted least squares (lowess) regression, with
standard errors (shaded region) estimated with 1,000 bootstrapping
replicates, with resampling at the level of the subject.
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requiring rescue therapy within 3 days of initiation of treatment
and 16 requiring repeat therapy within 14 days.
The prevalence of anemia (Hb < 11 g/dL) at routine visits
did not follow the same pattern as transmission intensity and
was 15.4% in Kihihi, 25.3% in Walukuba, and 29.0% in
Nagongera (Table 2). To provide a historical comparison,
combined anemia data were compared with national esti-
mates for children 6–59 months of age from the Uganda 2009
MIS18 and 2011 Demographic and Health Survey (DHS).23
The prevalence of anemia decreased dramatically among the
2009 MIS, the 2011 DHS, and the cohort studies (Table 3). In
addition, the prevalence of various degrees of anemia in
cohort subjects declined significantly when comparing values
at enrollment and the first routine visit with values during
the last 18 months of follow-up: Hb < 11 g/dL (26.3% ver-
sus 21.6%, P = 0.001), Hb < 10 g/dL (11.1% versus 7.7%,
P < 0.001), and Hb < 8 g/dL (1.6% versus 0.9%, P = 0.03).
Temporal changes in malaria metrics. Temporal trends in
measures of transmission, infection, and disease for the three
study sites are presented in Figure 5. At all three sites,
monthly estimates of aEIR were characterized by two annual
peaks from October to January and April to July. The timing
of the peaks varied somewhat and the amplitude of the peaks
varied greatly between sites and year to year. Monthly esti-
mates of malaria incidence followed similar temporal trends
as estimates of transmission, with two annual peaks and
appreciable changes between years. However, the relative
difference in malaria incidence between the high- and low-
transmission seasons was less pronounced in Nagongera, the
site with the highest transmission intensity. Parasite preva-
lence was estimated every 3 months and did not reflect the
same degree of temporal variation as measures of transmis-
sion and disease. Only in Kanungu, there were appreciable
temporal changes in parasite prevalence. In addition, there
were no significant changes in parasite densities over time at
any of the three sites (data not shown). Comparing malaria
metrics between the first (October 2011–September 2012) and
second (October 2012–September 2013) years of observation
yielded interesting differences between sites. In Walukuba,
there were significant decreases in the aEIR (4.0 versus 1.8, P =
0.007) and malaria incidence (0.51 PPY versus 0.31 PPY, P =
0.001), with a modest decrease in parasite prevalence that did
not reach statistical significance (9.0% versus 5.7%, P = 0.11).
In Kihihi, there were significant increases in aEIR (18.9 versus
46.6, P = 0.001), malaria incidence (0.97 PPY versus 1.93 PPY,
P < 0.001), and parasite prevalence (7.6% versus 11.6%,
P < 0.001). In Nagongera, there was a significant decrease in
aEIR (348 versus 267, P = 0.008), a significant increase in
malaria incidence (2.33 PPY versus 3.30 PPY, P < 0.001), and
no significant change in parasite prevalence (27.4% versus
28.7%, P = 0.50). At all three sites, there were no significant
differences in average monthly rainfall between the 2 years of
observation (data not shown).
DISCUSSION
We investigated the relationship between malaria transmis-
sion, infection, and disease at three sites in Uganda with var-
ied transmission intensity. The study benefited from detailed
knowledge of the study sites, dynamic cohorts in which all
participants received LLINs and prompt treatment of malaria
with an ACT, and entomologic data collected from the house-
holds occupied by the cohort members. We found 1) highly
seasonal transmission and varied relationships between mea-
sures of transmission, infection, and disease; 2) decreasing
incidence in the peri-urban site, but high and increasing inci-
dence in the two rural sites; 3) very low incidence of severe
disease; and 4) low and decreasing prevalence of anemia at all
sites. These results highlight the current complexity of malaria
dynamics in Uganda.
Malaria surveillance, monitoring, and evaluation are critical
for estimating disease burden and assessing the level of coverage
and impact of control interventions. In highly endemic areas,
such as Uganda, malaria indicators are largely derived from
nationally representative household surveys and routine health
information systems.24 Household surveys are useful for esti-
mating the coverage level of key control interventions such as
LLINs, IRS, and ACT use as well as some indicators of disease
burden such as parasite prevalence and anemia. However, these
surveys are cross-sectional in nature and infrequently done in
resource-limited countries, limiting their ability to monitor
temporal trends and provide detailed information on disease
epidemiology. Data from routine health information systems,
generally health facility–based reporting of malaria cases, are
used to estimate malaria morbidity and mortality and monitor
temporal trends. However, in resource-limited countries where
the malaria burden is highest, the quality of these data is often
poor because of lack of laboratory confirmation, incomplete
reporting, and failure to capture cases outside the public health
Table 3
Comparison of prevalence of anemia between national surveys and
cohort studies
Measurement 2009 MIS17 2011 DHS21 2011–2013 Cohort studies†
Number of observations* 3529 2142 6816
Hb < 11 g/dL 62.3% 49.3% 22.8%
Hb < 10 g/dL 40.6% N/A 8.5%
Hb < 8 g/dL 9.7% 4.7% 1.0%
DHS =Demographic and Health Survey; Hb = hemoglobin;MIS =Malaria Indicator Survey.
*Includes children 6–59 months of age.
†Data presented in this paper.
Figure 4. Malaria incidence by age at the three study sites with
varying malaria transmission intensity. Curves for each site were
fitted using locally weighted least squares (lowess) regression, with
standard errors (shaded region) estimated with 1,000 bootstrapping
replicates, with resampling at the level of the subject.
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sector. There has been a strong push for improving surveillance
in countries approaching malaria elimination.25 However,
there is also a great need to improve malaria surveillance in
highly endemic countries where the focus remains disease con-
trol. In this report, we describe the findings of a comprehensive
malaria surveillance program conducted in three areas of
Uganda with differing disease epidemiology.
To provide context for the data presented in this report it is
useful to review recent trends in the coverage of key control
interventions in Uganda.18,23,26 Considering use of bed nets,
nationally representative estimates of LLIN coverage, defined
as the proportion of households with at least one LLIN,
increased from 16% in 2006, to 47% in 2009, to 60% in 2011.
In the three subcounties included in this report, estimates
ranged from 51 to 79%. However, the proportion of house-
holds with at least one LLIN per two persons was much lower
(17–36%), suggesting low LLIN coverage and a considerable
intra-household ownership gap. Considering IRS, in 2006,
Uganda implemented the first large-scale program since the
1960s. This program has focused principally on 10 districts in
northern Uganda, and on a national scale only 6–7% of house-
holds reported receiving IRS between 2006 and 2011. Consid-
ering malaria therapy, the proportion of children under 5 years
with recent fever treated for malaria who were given an ACT
dramatically increased in Uganda from 5% in 2006, to 39%
in 2009, to 69% in 2011. Indeed this trend appears to have
Figure 5. Temporal trends in measures of malaria infection, transmission, and disease at the three study sites. Entomological inoculation rates
(dashed lines) for each site were estimated using the product of human biting rates (averaged monthly) and sporozoite rates (averaged yearly).
Malaria incidence (solid lines) for each site was estimated using mean monthly incidence; prevalence (dots) for each site was estimated from active
surveillance occurring every 3 months. Estimates of average monthly rainfall were obtained from the NASA Tropical Rainfall Measuring Mission
Project.
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continued, as in 2012 estimates for this indicator ranged from
75–82% for the subcounties included in this report (Sarah G.
Staedke, unpublished data).
Comparison of the relationships between measures of
transmission, infection, and disease within and between the
three sites provided a picture of the contrasting epidemiology
of malaria in Uganda. Transmission (defined by EIR) was
highly seasonal, with two annual peaks at all sites, but
between sites there was marked variation in the magnitude
of these peaks and in changes from year to year. Compared
with Walukuba, the EIR for the full observation period was
approximately 10-fold higher in Kihihi and 100-fold higher in
Nagongera. In Walukuba and Nagongera, there were signifi-
cant decreases in EIR from the first year to the next, while in
Kihihi, there was a significant increase in EIR. Of note, differ-
ences in EIR between the sites and over time were primarily
driven by differences in the numbers of mosquitoes collected
(human biting rate) and not by the proportion of infected
mosquitoes (sporozoite rate). Although EIR is considered
the gold standard metric of malaria transmission, the large
uncertainty inherent in measuring the human biting rate and
the sporozoite rate limit the precision and accuracy of EIR
across small temporal and spatial scales.27 In contrast to trans-
mission, our measure of infection (defined as the parasite
prevalence in cohort children 0.5–10 years of age) showed less
variation over time. Although parasite prevalence is a useful
tool for rapid estimates of endemicity, it is not a direct mea-
sure of transmission intensity, and can become saturated at
higher intensities.28,29 Indeed, large changes in EIR can lead
to relatively small changes in parasite prevalence, as preva-
lence is influenced by heterogeneous biting, multiple infec-
tions, acquired immunity, and antimalarial therapy.27 Our
most direct measure of disease burden was childhood malaria
incidence. Considering temporal and geographic variation,
incidence correlated well with EIR. In our two lower trans-
mission sites, changes in malaria incidence from the first to
second year correlated well with changes in EIR. However, in
our highest transmission intensity site, malaria incidence
increased significantly from the first to second year despite a
decrease in EIR, suggesting that associations between esti-
mates of transmission intensity and disease incidence are
complex, especially in high transmission intensity settings.
Although this study was not designed to make causal infer-
ences about factors responsible for changes in malaria over time,
observed differences between our low- and high-transmission
cohorts, all of whom received LLINs and prompt effective
treatment of malaria, allow some conclusions. Our lowest
transmission intensity site, a peri-urban setting, was the only
site that exhibited a significant decline in measures of transmis-
sion and disease. A similar decline in malaria incidence was
reported from 2004 to 2008 in a cohort of children living in the
urban center of Kampala.30 Many reports from Africa have
demonstrated significant declines in malaria morbidity and
mortality following the scale-up of available malaria control
interventions such as LLINs and ACTs, although most of these
reports come from areas with low to moderate baseline levels
of transmission intensity.1,2,4–6,31,32 In contrast, recent reports
from sites in Malawi with intermediate to high transmission
intensity have documented no change or increased malaria
burden, despite a modest scale-up of control interventions.7,33
In a high transmission site from Senegal, scale-up of LLINs was
initially associated with a decline in malaria incidence but sub-
sequently malaria incidence rose to almost pre-intervention
levels, corresponding with increasing pyrethroid resistance of
mosquito vectors.8 Data from our two highest transmission
sites also showed temporal increases in malaria incidence. Of
note, several reports from Uganda have shown a dramatic
increase in the prevalence of pyrethroid resistance among mos-
quito vectors over the last 5 years.34–36 Taken together, our
findings suggest that the impacts of scale-up of control inter-
ventions are site specific and depend on the underlying epide-
miology of malaria. For example, mathematical models have
predicted bigger impacts over a shorter time frame following
scale-up of LLINs when baseline levels of transmission inten-
sity are lower.37 Indeed, in high-transmission settings that are
characteristic much of Uganda, reductions in malaria incidence
may require higher coverage levels, longer durations, and pos-
sibly additional interventions. This “race” to reduce the burden
of malaria must be carried out under the constant threat of the
emergence and spread of insecticide and drug resistance.
An encouraging finding from this study was the remarkably
low incidence of severe malaria and malaria-associated mor-
tality. Historically it has been estimated that each clinical
attack of malaria among African children is associated with a
2% risk of severe disease and a mortality rate of 0.5%.38 In
this study, with over 2,500 treatments for malaria, the risk of
severe malaria was < 0.3%, and there were no episodes of
cerebral malaria or malaria-associated death. In addition, the
prevalence of anemia was surprisingly low across all sites and
declined over the period of observation. Indeed, nationally
representative surveys in Uganda suggest that there has been
a marked reduction in the prevalence of anemia and under
five mortality in recent years.18,23,26 Similarly, low rates of
severe malaria and mortality have been found elsewhere
whenever malaria studies provide high-quality health care.30
We hypothesize that the encouraging findings from this study
and possibly for Uganda as a whole can be largely attributed
to prompt and effective therapy with AL, which results in
rapid parasite clearance, resolution of symptoms, and Hb
recovery, thus reducing the risk of progression to severe dis-
ease.39,40 Another encouraging finding was the relatively low
prevalence of anemia in our cohorts, which appeared to be
decreasing over time, consistent with recent trends from
national surveys. We believe that decreasing anemia may also
have been due to prompt and effective treatment with AL,
along with other routine measures such as deworming and
iron supplementation.
There were several limitations to this study. First, estimates
of parasite prevalence were based on microscopy and may have
significantly underestimated the true prevalence of infection.
Indeed, there is an increasing appreciation of the role of asymp-
tomatic carriage in transmission and more sensitive methods,
such as polymerase chain reaction (PCR), have revealed that
the proportion of infections due to sub-patent parasitemia (i.e.,
not detected by microscopy) is inversely proportional to trans-
mission intensity.16 Second, the assessment of LLIN use in both
the cohort studies and complimentary community surveys was
by self-report and was not based on directly observed LLIN
usage, which may have overestimated the utilization of
LLINs.41 Finally, the descriptive nature of the study limits our
capacity to make causal inference in terms of the potential
impact of control interventions on our outcome measures.
In summary, despite reports of decreasing malaria burden
across many parts of sub-Saharan Africa, the burden continues
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to be very high in Uganda. Indeed, the incidence of malaria
rose in our two rural cohorts from 2011 to 2013. The use of
both LLIN and ACTs may be sufficient for minimizing the
severity of disease, improving child health, and reducing
childhood mortality at the level of an individual. However,
in areas with high transmission intensity, reducing morbidity
will likely require higher community-wide coverage of these
interventions and consideration of additional interventions
such as expansion of IRS, larval source management, and
other novel vector control strategies, chemoprevention at the
individual and/or community level, mass drug administration,
and/or an effective vaccine. Indeed, the true prevalence of
parasitemia in our study sites was likely higher than our esti-
mates based on microscopy, highlighting the challenges of
malaria control and elimination when the reservoir of infec-
tion is so large. High-transmission countries such as Uganda
already bear a disproportionate burden of this terrible disease
and will likely require further scaling up of widely accepted
existing interventions and possibly novel approaches to realize
the successes now being celebrated in other parts of the world.
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